Judy LeBrew

Person

Judy LeBrew is a guest who discussed Piper Sandler and its stock ticker, PIPR.

What Judy LeBrew has said on podcasts

1 statement

on AstraZeneca investment and cancer-drug collaboration with Summit TherapeuticsPositiveSep 29, 2026· Stock Movers
AstraZeneca agreed to invest $2 billion in Summit Therapeutics and collaborate on a cancer drug.
“AstraZeneca agreed to invest $2 billion in Summit Therapeutics to collaborate on a promising new cancer medication”
Listen at 2:06
Open the episode · Piper Sandler Drops, Summit Therapeutics Jumps, Fair Isaac Sinks as New Policy Seen Spurring Competition

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.